$264 Million Settlement in EpiPen Price Gouging Litigation | Proskauer - Minding Your Business
On July 11, 2022, the United States District Court for the District of Kansas approved a $264 million settlement against Mylan and certain of its subsidiaries in the case In Re EpiPen...
Source: jdsupra.com